Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000343452 | SCV000441613 | likely benign | Deficiency of ferroxidase | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000376274 | SCV000484044 | likely benign | Hermansky-Pudlak syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000343452 | SCV000760126 | benign | Deficiency of ferroxidase | 2025-01-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001560095 | SCV001782435 | likely benign | not provided | 2020-10-28 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001560095 | SCV005260893 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000116822 | SCV000150896 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Genome Diagnostics Laboratory, |
RCV001560095 | SCV001808959 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000116822 | SCV001963975 | benign | not specified | no assertion criteria provided | clinical testing |